Yoyo dieting alters gut health, driving weight regain and inflammation

Researchers from Deakin University reveal how yoyo dieting disrupts gut health, leading to weight regain and obesity-related complications. The study highlights the roles of gut microbiota, hormones, and inflammation in the weight cycling process.

Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 – Biotech Investments

EQS-News: ABIVAX / Key word(s): Conference Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod

January 25, 2024

Ebola Vaccine Given Post-Infection Protects Against Death

Vaccination with the Ebola Zaire vaccine (rVSVΔG-ZEBOV-GP; Ervebo) was associated with a significantly lower risk of death in patients with confirmed Ebola disease, even for

February 14, 2024

CareAbout Health Selects Innovaccer to Scale VBC for Expanding Provider Network

What You Should Know: – CareAbout, a healthcare management services company, has selected Innovaccer’s data platform and analytics solutions to help its providers achieve their

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.